Role of sodium-glucose cotransporter 2 inhibitors in cardiovascular events in patients with heart failure
Heart failure is a major cause of morbidity and mortality globally, with a significant impact on both patients’ quality of life and healthcare costs. Sodium-glucose cotransporter 2 inhibitors (SGLT2-I), initially developed for the treatment of type 2 diabetes mellitus, have attracted particular int...
Saved in:
| Main Authors: | Eva Muja, Letizia Giuseppina Floccari, Artan Simaku, Klodeta Grosha, Besim Lama, Ilirian Laçi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2025-07-01
|
| Series: | Italian Journal of Medicine |
| Subjects: | |
| Online Access: | https://www.italjmed.org/ijm/article/view/1997 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Sodium-Glucose Cotransporter Type 2 Inhibitors on The Development and Course of Atrial Fibrillation
by: D. A. Ishmaev, et al.
Published: (2025-01-01) -
Secondary Erythrocytosis Among Type 2 Diabetes Mellitus Patients With Hypogonadism Using Sodium‐Glucose Cotransporter 2 Inhibitors and Testosterone Replacement Therapy
by: Maharan Kabha, et al.
Published: (2025-07-01) -
Efficacy and Safety of Bexagliflozin, a Selective Sodium-Glucose Cotransporter-2 Inhibitor, in Type 2 Diabetes: A Systematic Review and Meta-Analysis
by: A.B.M. Kamrul-Hasan, et al.
Published: (2025-01-01) -
Comparative effectiveness and safety of sodium-glucose cotransporter 2 inhibitors vs glucagon-like peptide 1 receptor agonists in elderly patients with type 2 diabetes mellitus: a meta-analysis
by: Yao Wang, et al.
Published: (2025-08-01) -
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Stage 4 Cardiovascular–Kidney–Metabolic Syndrome: A Propensity Score–Matched Study
by: Tao Liu, et al.
Published: (2025-08-01)